Abstract
Genetic alterations in key genes are distinctive of a cancer cell. But the tumors also undergo other changes specific of the malignant transformation that do not affect the sequence of DNA. These are given the term epigenetic lesions, and the main one is aberrant methylation. In this review we focus in how promoter hypermethylation silences the expression of genes contributing to the neoplastic phenotype. Well recognized tumor suppressor genes such as p16/INK4a, BRCA1, Rb and V H L became hypermethylated in sporadic tumors with very selective patterns. Other genes recently characterized such as p14/ARF, LKB1, p73, E-cadherin and DAP-Kinase are also epigenetically inactivated in tumors. Furthermore, the methylation mediated silencing of DNA repair and detoxifier genes, such as the mismatch repair gene h MLH1, the alkylrepair MGMT and the carcinogen-protector GSTP1, may cause important genomic damage and mutations. All this recent data may provide a new avenue in how we understand the development, diagnosis and treatment of cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 61-66 |
| Number of pages | 6 |
| Journal | Clinical and Translational Oncology |
| Volume | 2 |
| Issue number | 2 |
| State | Published - Mar 2000 |
Fingerprint
Keywords
- DNA repair genes
- Epigenetic
- Human cancer
- Methylation
- Promoter
- Tumor suppressor Genes
ASJC Scopus subject areas
- Oncology
- Cancer Research
Cite this
Beyond the genetic lesions : Gene inactivation by promoter hypermethylation in human cancer. / Esteller, Manel; Baylin, Stephen B; Herman, James G.
In: Clinical and Translational Oncology, Vol. 2, No. 2, 03.2000, p. 61-66.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Beyond the genetic lesions
T2 - Gene inactivation by promoter hypermethylation in human cancer
AU - Esteller, Manel
AU - Baylin, Stephen B
AU - Herman, James G.
PY - 2000/3
Y1 - 2000/3
N2 - Genetic alterations in key genes are distinctive of a cancer cell. But the tumors also undergo other changes specific of the malignant transformation that do not affect the sequence of DNA. These are given the term epigenetic lesions, and the main one is aberrant methylation. In this review we focus in how promoter hypermethylation silences the expression of genes contributing to the neoplastic phenotype. Well recognized tumor suppressor genes such as p16/INK4a, BRCA1, Rb and V H L became hypermethylated in sporadic tumors with very selective patterns. Other genes recently characterized such as p14/ARF, LKB1, p73, E-cadherin and DAP-Kinase are also epigenetically inactivated in tumors. Furthermore, the methylation mediated silencing of DNA repair and detoxifier genes, such as the mismatch repair gene h MLH1, the alkylrepair MGMT and the carcinogen-protector GSTP1, may cause important genomic damage and mutations. All this recent data may provide a new avenue in how we understand the development, diagnosis and treatment of cancer.
AB - Genetic alterations in key genes are distinctive of a cancer cell. But the tumors also undergo other changes specific of the malignant transformation that do not affect the sequence of DNA. These are given the term epigenetic lesions, and the main one is aberrant methylation. In this review we focus in how promoter hypermethylation silences the expression of genes contributing to the neoplastic phenotype. Well recognized tumor suppressor genes such as p16/INK4a, BRCA1, Rb and V H L became hypermethylated in sporadic tumors with very selective patterns. Other genes recently characterized such as p14/ARF, LKB1, p73, E-cadherin and DAP-Kinase are also epigenetically inactivated in tumors. Furthermore, the methylation mediated silencing of DNA repair and detoxifier genes, such as the mismatch repair gene h MLH1, the alkylrepair MGMT and the carcinogen-protector GSTP1, may cause important genomic damage and mutations. All this recent data may provide a new avenue in how we understand the development, diagnosis and treatment of cancer.
KW - DNA repair genes
KW - Epigenetic
KW - Human cancer
KW - Methylation
KW - Promoter
KW - Tumor suppressor Genes
UR - http://www.scopus.com/inward/record.url?scp=84873368582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84873368582&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84873368582
VL - 2
SP - 61
EP - 66
JO - Clinical and Translational Oncology
JF - Clinical and Translational Oncology
SN - 1699-048X
IS - 2
ER -